Clinical Trials — Currently Recruiting (Australia)

Ask your doctor whether you or your child may be eligible for any of these trials.

1. 1.

   Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

   Recruiting — Phase 3 — University College, London

   https://clinicaltrials.gov/study/NCT04685616

2. 2.

   Zenith LAA Occlusion System

   Recruiting — Na — AuriGen Medical Ltd

   https://clinicaltrials.gov/study/NCT05951101

3. 3.

   Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

   Recruiting — Boston Scientific Corporation

   https://clinicaltrials.gov/study/NCT06894498

4. 4.

   Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy

   Recruiting — Na — Nova Eye Medical Pty Ltd.

   https://clinicaltrials.gov/study/NCT05570591

5. 5.

   A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

   Recruiting — Phase 3 — Cybin IRL Limited

   https://clinicaltrials.gov/study/NCT06793397

6. 6.

   A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

   Recruiting — Phase 3 — Epizyme, Inc.

   https://clinicaltrials.gov/study/NCT04224493

7. 7.

   A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

   Recruiting — Phase 2 — Children's Oncology Group

   https://clinicaltrials.gov/study/NCT04684368

8. 8.

   Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

   Recruiting — Phase 3 — United Therapeutics

   https://clinicaltrials.gov/study/NCT05943535

9. 9.

   This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

   Recruiting — Phase 3 — Pfizer

   https://clinicaltrials.gov/study/NCT06758401

10. 10.

    A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

    Recruiting — Phase 1 — Nimbus Wadjet, Inc.

    https://clinicaltrials.gov/study/NCT06898450

11. 11.

    A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

    Recruiting — Phase 3 — Eli Lilly and Company

    https://clinicaltrials.gov/study/NCT07174336

12. 12.

    A Study of Brenipatide in Adult Participants With Major Depressive Disorder

    Recruiting — Phase 3 — Eli Lilly and Company

    https://clinicaltrials.gov/study/NCT07412756

13. 13.

    A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

    Recruiting — Phase 3 — Bellus Health Inc. - a GSK company

    https://clinicaltrials.gov/study/NCT05600777

14. 14.

    Staphylococcus Aureus Network Adaptive Platform Trial

    Recruiting — Phase 4 — University of Melbourne

    https://clinicaltrials.gov/study/NCT05137119

15. 15.

    Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

    Recruiting — Phase 3 — Boehringer Ingelheim

    https://clinicaltrials.gov/study/NCT06151574

16. 16.

    A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

    Recruiting — Phase 3 — Hoffmann-La Roche

    https://clinicaltrials.gov/study/NCT05797610

17. 17.

    The National Australian HCV Point-of-Care Testing Program

    Recruiting — Kirby Institute

    https://clinicaltrials.gov/study/NCT05042544

18. 18.

    A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

    Recruiting — Phase 2 — Children's Oncology Group

    https://clinicaltrials.gov/study/NCT06368817

19. 19.

    JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

    Recruiting — Phase 3 — University of Texas Southwestern Medical Center

    https://clinicaltrials.gov/study/NCT02468024

20. 20.

    Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)

    Recruiting — Na — Rigicon, Inc.

    https://clinicaltrials.gov/study/NCT05574868

21. 21.

    A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

    Recruiting — Phase 3 — Verastem, Inc.

    https://clinicaltrials.gov/study/NCT06072781

22. 22.

    Microbial Restoration in Inflammatory Bowel Diseases

    Recruiting — Phase 1 — St Vincent's Hospital Melbourne

    https://clinicaltrials.gov/study/NCT04970446

23. 23.

    Platform of Randomized Adaptive Clinical Trials in Critical Illness

    Recruiting — Na — University Health Network, Toronto

    https://clinicaltrials.gov/study/NCT05440851

24. 24.

    TrialNet Pathway to Prevention of T1D

    Recruiting — University of South Florida

    https://clinicaltrials.gov/study/NCT00097292

25. 25.

    A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

    Recruiting — Phase 3 — Inventiva Pharma

    https://clinicaltrials.gov/study/NCT04849728

26. 26.

    A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

    Recruiting — Phase 3 — Janssen Research & Development, LLC

    https://clinicaltrials.gov/study/NCT07276399

27. 27.

    A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis

    Recruiting — Phase 2 — Takeda

    https://clinicaltrials.gov/study/NCT05037760

28. 28.

    A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

    Recruiting — Phase 1 — DualityBio Inc.

    https://clinicaltrials.gov/study/NCT05150691

29. 29.

    Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

    Recruiting — Na — Melanoma and Skin Cancer Trials Limited

    https://clinicaltrials.gov/study/NCT03860883

30. 30.

    A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)

    Recruiting — Phase 2 — Denali Therapeutics Inc.

    https://clinicaltrials.gov/study/NCT05371613

31. 31.

    A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

    Recruiting — Phase 2 — Novartis Pharmaceuticals

    https://clinicaltrials.gov/study/NCT07047118

32. 32.

    Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

    Recruiting — Phase 3 — National Cancer Institute (NCI)

    https://clinicaltrials.gov/study/NCT06568172

33. 33.

    Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

    Recruiting — Phase 3 — Novartis Pharmaceuticals

    https://clinicaltrials.gov/study/NCT05827081

34. 34.

    Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

    Recruiting — Phase 3 — Kartos Therapeutics, Inc.

    https://clinicaltrials.gov/study/NCT06479135